--------------------
文献抄録 Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study):a multicentre, randomised, open-label, phase 3 trial/Patterns of progression in pediatric patients with high-grade glioma or diffuse intrinsic pontine glioma treated with bevacizumab-based therapy at diagnosis
黒住 和彦
1
1岡山大学脳神経外科
pp.481
発行日 2015年5月10日
Published Date 2015/5/10
DOI https://doi.org/10.11477/mf.1436203053
- フリーアクセス
- 1ページ目
Copyright © 2015, Igaku-Shoin Ltd. All rights reserved.